Cargando…

Suppressed immune profile in children with combined type 1 diabetes and celiac disease

Children diagnosed with a combination of type 1 diabetes (T1D) and celiac disease (CD) show a dysregulated T helper type 1 (Th1)/Th17 response. Besides the cellular involvement, several soluble immune markers are involved in the autoimmune process of both T1D and CD. Only few studies have examined t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tompa, A., Åkesson, K., Karlsson, S., Faresjö, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419926/
https://www.ncbi.nlm.nih.gov/pubmed/32415995
http://dx.doi.org/10.1111/cei.13454
_version_ 1783569950814765056
author Tompa, A.
Åkesson, K.
Karlsson, S.
Faresjö, M.
author_facet Tompa, A.
Åkesson, K.
Karlsson, S.
Faresjö, M.
author_sort Tompa, A.
collection PubMed
description Children diagnosed with a combination of type 1 diabetes (T1D) and celiac disease (CD) show a dysregulated T helper type 1 (Th1)/Th17 response. Besides the cellular involvement, several soluble immune markers are involved in the autoimmune process of both T1D and CD. Only few studies have examined the peripheral pattern of different cytokines, chemokines and acute‐phase proteins (APP) in children with combined T1D and CD. To our knowledge, no studies have evaluated the serum levels of adipocytokines and matrix metalloproteinases (MMPs) in this context. The purpose of the present study was to acquire more knowledge and to gain deeper understanding regarding the peripheral immunoregulatory milieu in children with both T1D and CD. The study included children diagnosed with both T1D and CD (n = 18), children with T1D (n = 27) or CD (n = 16) and reference children (n = 42). Sera were collected and analysis of 28 immune markers (cytokines, chemokines, APPs, adipocytokines and MMPs) was performed using the Luminex technique. The major findings showed that children with a double diagnosis had lower serum levels of interleukin (IL)‐22, monocyte chemoattractant protein (MIP)‐1α, monocyte chemoattractant protein (MCP)‐1, procalcitonin, fibrinogen, visfatin and matrix metalloproteinase (MMP)‐2. These results indicate a suppressed immune profile in children with combined T1D and CD, including Th17 cytokines, chemokines, APPs, adipocytokines and MMPs. We conclude that, besides cytokines and chemokines, other immune markers, e.g. APPs, adipocytokines and MMPs, are of importance for further investigations to elucidate the heterogeneous immune processes present in patients diagnosed with T1D in combination with CD.
format Online
Article
Text
id pubmed-7419926
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74199262020-08-12 Suppressed immune profile in children with combined type 1 diabetes and celiac disease Tompa, A. Åkesson, K. Karlsson, S. Faresjö, M. Clin Exp Immunol Original Articles Children diagnosed with a combination of type 1 diabetes (T1D) and celiac disease (CD) show a dysregulated T helper type 1 (Th1)/Th17 response. Besides the cellular involvement, several soluble immune markers are involved in the autoimmune process of both T1D and CD. Only few studies have examined the peripheral pattern of different cytokines, chemokines and acute‐phase proteins (APP) in children with combined T1D and CD. To our knowledge, no studies have evaluated the serum levels of adipocytokines and matrix metalloproteinases (MMPs) in this context. The purpose of the present study was to acquire more knowledge and to gain deeper understanding regarding the peripheral immunoregulatory milieu in children with both T1D and CD. The study included children diagnosed with both T1D and CD (n = 18), children with T1D (n = 27) or CD (n = 16) and reference children (n = 42). Sera were collected and analysis of 28 immune markers (cytokines, chemokines, APPs, adipocytokines and MMPs) was performed using the Luminex technique. The major findings showed that children with a double diagnosis had lower serum levels of interleukin (IL)‐22, monocyte chemoattractant protein (MIP)‐1α, monocyte chemoattractant protein (MCP)‐1, procalcitonin, fibrinogen, visfatin and matrix metalloproteinase (MMP)‐2. These results indicate a suppressed immune profile in children with combined T1D and CD, including Th17 cytokines, chemokines, APPs, adipocytokines and MMPs. We conclude that, besides cytokines and chemokines, other immune markers, e.g. APPs, adipocytokines and MMPs, are of importance for further investigations to elucidate the heterogeneous immune processes present in patients diagnosed with T1D in combination with CD. John Wiley and Sons Inc. 2020-06-14 2020-09 /pmc/articles/PMC7419926/ /pubmed/32415995 http://dx.doi.org/10.1111/cei.13454 Text en © 2020 The Authors. Clinical & Experimental Immunology published by John Wiley and Sons Ltd on behalf of British Society for Immunology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Tompa, A.
Åkesson, K.
Karlsson, S.
Faresjö, M.
Suppressed immune profile in children with combined type 1 diabetes and celiac disease
title Suppressed immune profile in children with combined type 1 diabetes and celiac disease
title_full Suppressed immune profile in children with combined type 1 diabetes and celiac disease
title_fullStr Suppressed immune profile in children with combined type 1 diabetes and celiac disease
title_full_unstemmed Suppressed immune profile in children with combined type 1 diabetes and celiac disease
title_short Suppressed immune profile in children with combined type 1 diabetes and celiac disease
title_sort suppressed immune profile in children with combined type 1 diabetes and celiac disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419926/
https://www.ncbi.nlm.nih.gov/pubmed/32415995
http://dx.doi.org/10.1111/cei.13454
work_keys_str_mv AT tompaa suppressedimmuneprofileinchildrenwithcombinedtype1diabetesandceliacdisease
AT akessonk suppressedimmuneprofileinchildrenwithcombinedtype1diabetesandceliacdisease
AT karlssons suppressedimmuneprofileinchildrenwithcombinedtype1diabetesandceliacdisease
AT faresjom suppressedimmuneprofileinchildrenwithcombinedtype1diabetesandceliacdisease